their optimum working dilutions by titration
assay.
References:
1. Chorvath, B., et al., Neoplasma, 34, 685 (1987).
2. Chorvath, B., et al., in Leukocyte Typing IV,
Knapp, W. (ed.), p.
of cells under study
and the sensitivity of the instrument used.
References
1. Chorvath, B., et al., Neoplasma, 34, 685 (1987).
2. Chorvath, B., et al., in Leukocyte Typing IV, Knapp,
W. (ed.), p
determine their optimum working
dilutions by titration assay.
References
1. Chorvath, B., et al., Neoplasma, 34, 685 (1987).
2. Chorvath, B., et al., in Leukocyte Typing IV, Knapp,
W. (ed.)
percentage
positive using saturating monoclonal antibody levels.
References
1. Chorvath, B., et al., Neoplasma, 34, 685 (1987).
2. Chorvath, B., et al., in Leukocyte Typing IV,
Knapp, W. (ed.)
leucocyte gates by inappropriate
subpopulation(s).
References
Chorvath, B., et al., Neoplasma, 34, 685 (1987).
Chorvath, B., et al., In: Leukocyte Typing IV, Knapp, W.
(Ed.), p. 634, Oxford University
. Commun.,
38, 533-538 (1970).
32. Bredt, D. and Snyder, S., Proc. Nat, Acad. Sci.
USA, 87, 682-685 (1990).
33. Busse, R. and Mulsch, A. Febs Lett., 265, 133-136
(1990).
34. Watterson, D. et al
Isolation of nitric
oxide synthetase, a calmodulin-requiring enzyme.
Proc. Natl. Acad. Sci. USA, 87, 685-689 (1990).
8. Kojima, H., et al., Development of a fluorescent
indicator for nitric oxide based
Isolation of nitric
oxide synthetase, a calmodulin requiring enzyme.
Proc. Natl. Acad. Sci. USA, 87, 685-689 (1990).
8. Pollock, J.S., et al., Purification and
characterization of particulate endothelium-derived
001139526.1 ,NP_001139527.1 ,NP_009292.1 y n/d y
698 a1 Syntrophin S4688 6640 SNTA1 P NP_003089.1 n/d n/d y
685 Sp1 S9809 6667 SP1 P NP_003100.1 y n/d n/d
656 Spectrin (a and ?) S3396 6708 SPTA1 M NP_003117.2
001139526.1 ,NP_001139527.1 ,NP_009292.1 y n/d y
698 a1 Syntrophin S4688 6640 SNTA1 P NP_003089.1 n/d n/d y
685 Sp1 S9809 6667 SP1 P NP_003100.1 y n/d n/d
656 Spectrin (a and ?) S3396 6708 SPTA1 M NP_003117.2
001139526.1 ,NP_001139527.1 ,NP_009292.1 y n/d y
698 a1 Syntrophin S4688 6640 SNTA1 P NP_003089.1 n/d n/d y
685 Sp1 S9809 6667 SP1 P NP_003100.1 y n/d n/d
656 Spectrin (a and ?) S3396 6708 SPTA1 M NP_003117.2
n/d
685 Sp1 S9809 P y n/d n/d
686 Spred-2 S7320 P y y y
687 Striatin S0696 P n/d y y
688 Substance P Receptor S8305 P y y y
689 SMAC/Diablo S0941 P y y n/d
690 SUMO-1 S8070 P y n/d n/d
691 SUMO-1